IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $811,550 | +231110.8% | 115,277 | +100.4% | 0.01% | +100.0% |
| Q1 2023 | $351 | -42.0% | 57,527 | -39.2% | 0.01% | -58.3% |
| Q4 2022 | $605 | -99.9% | 94,629 | +20.1% | 0.01% | -25.0% |
| Q3 2022 | $755,000 | -24.4% | 78,780 | -12.9% | 0.02% | -38.5% |
| Q2 2022 | $999,000 | +97.4% | 90,494 | +198.0% | 0.03% | +116.7% |
| Q1 2022 | $506,000 | -69.7% | 30,370 | -65.3% | 0.01% | -57.1% |
| Q4 2021 | $1,671,000 | +41.3% | 87,532 | +82.4% | 0.03% | +47.4% |
| Q3 2021 | $1,183,000 | -75.1% | 47,982 | -68.0% | 0.02% | -80.0% |
| Q1 2021 | $4,752,000 | +441.8% | 150,091 | +369.9% | 0.10% | +120.9% |
| Q2 2020 | $877,000 | +496.6% | 31,938 | +68.1% | 0.04% | +975.0% |
| Q3 2017 | $147,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |